title: Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?
authors.forename: Y
authors.initials: Y
authors.lastname: Loh
authors.forename: Y
authors.initials: Y
authors.lastname: Oyama
authors.forename: L
authors.initials: L
authors.lastname: Statkute
authors.forename: L
authors.initials: L
authors.lastname: Verda
authors.forename: K
authors.initials: K
authors.lastname: Quigley
authors.forename: K
authors.initials: K
authors.lastname: Yaung
authors.forename: W
authors.initials: W
authors.lastname: Barr
authors.forename: B
authors.initials: B
authors.lastname: Jovanovic
authors.forename: R K
authors.initials: RK
authors.lastname: Burt
mesh_terms: D000328:Adult; D015551:Autoimmunity; D005260:Female; D006086:Graft vs Host Disease; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006650:Histocompatibility Testing; D006801:Humans; D012595:Scleroderma, Systemic / Q000628:therapy*; D013997:Time Factors; D019172:Transplantation Conditioning; D016896:Treatment Outcome